Recent Progress in Benzothiazole-based Molecules for Cognitive Dysfunction

Current treatment of cognitive dysfunction is limited and a significant challenge in therapy due to the limited efficacy of available acetylcholinesterase inhibitors (AChEIs) and their side effects. Therefore, in medicinal chemistry, the search for safer, selective, and multitarget-directed therapeutic agents has attracted much attention. Benzothiazole is one of the most promising heterocyclic frameworks, particularly because it is highly bioisosteric, has a promising pharmacokinetic profile, and has high neuroprotective properties. The special structural characteristics of the benzothiazole nucleus enable interactions with a wide variety of biological targets associated with memory impairments and neurodegenerative disorders. Based on the structure of the known drug, a series of novel benzothiazole-based derivatives was rationally designed as potential anti-amnesic agents in the present study. The therapeutic significance of the benzothiazole functional group in the discovery of novel candidates for the management of cognitive dysfunction and memory-related disorders was highlighted.

Authors

Publication Details

Journal
Current Journal of Life Sciences
Published
2026-11-12
DOI
https://doi.org/10.2174/01305077157073261102203409
Primary Topic
Cholinesterase and Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Recent Progress in Benzothiazole-based Molecules for Cognitive Dysfunction

Lakshmi rajput, Anuradha Sharma
Current Journal of Life Sciences
Cholinesterase and Neurodegenerative Diseases
article

Recent Progress in Benzothiazole-based Molecules for Cognitive Dysfunction

Lakshmi rajput, Anuradha Sharma
article en

Abstract

Current treatment of cognitive dysfunction is limited and a significant challenge in therapy due to the limited efficacy of available acetylcholinesterase inhibitors (AChEIs) and their side effects. Therefore, in medicinal chemistry, the search for safer, selective, and multitarget-directed therapeutic agents has attracted much attention. Benzothiazole is one of the most promising heterocyclic frameworks, particularly because it is highly bioisosteric, has a promising pharmacokinetic profile, and has high neuroprotective properties. The special structural characteristics of the benzothiazole nucleus enable interactions with a wide variety of biological targets associated with memory impairments and neurodegenerative disorders. Based on the structure of the known drug, a series of novel benzothiazole-based derivatives was rationally designed as potential anti-amnesic agents in the present study. The therapeutic significance of the benzothiazole functional group in the discovery of novel candidates for the management of cognitive dysfunction and memory-related disorders was highlighted.

Current Journal of Life SciencesVol. 01
Cholinesterase and Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon